SNDL SNDL Inc. NASDAQ · United States

SNDL (SNDL) news

SNDL Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SNDL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest SNDL news

We have not published a story on SNDL yet. When there is news, it will appear here.

SNDL annual financials

Line	FY2025	FY2024
Revenue	C$946.4 million	C$920.4 million
Research and development	C$489,000	C$346,000
Net income (loss)	-C$15.8 million	-C$96.2 million
Cash from operations	C$70.9 million	C$54.9 million
Cash and equivalents	C$252.2 million	C$218.4 million
Short-term investments	C$484,000	C$27.6 million

Latest balance sheet, Dec 31, 2025 (40-F): cash and equivalents C$252.2 million, plus short-term investments of C$484,000, C$252.7 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about SNDL

What is the ticker symbol of SNDL?

SNDL Inc. trades under the ticker SNDL on NASDAQ.

Where is SNDL listed?

SNDL Inc. is listed on NASDAQ.

Which country or territory is SNDL listed under?

Our directory records SNDL Inc. under United States.

Does aibio.space cover SNDL?

aibio.space lists SNDL Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: SNDL

Members talk about SNDL (SNDL). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at SNDL, newest first. Each line links the filing it comes from.

Oct 15, 2026Listings
Reported a reverse stock split. SEC Form 6-K. Source
Sep 8, 2026Listings
Reported a reverse stock split. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:SNDL on TradingView.

Listing details

Company: SNDL Inc.
Ticker: SNDL
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction